PHP
Parkman Healthcare Partners’s Keros Therapeutics KROS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-217,753
| Closed | -$2.22M | – | 94 |
|
|
2025
Q1 | $2.22M | Sell |
217,753
-96,788
| -31% | -$986K | 0.26% | 72 |
|
|
2024
Q4 | $4.98M | Sell |
314,541
-107,241
| -25% | -$1.7M | 0.66% | 43 |
|
|
2024
Q3 | $24.5M | Buy |
421,782
+223,155
| +112% | +$13M | 3.13% | 5 |
|
|
2024
Q2 | $9.08M | Buy |
198,627
+20,292
| +11% | +$927K | 1.22% | 29 |
|
|
2024
Q1 | $11.8M | Sell |
178,335
-182,132
| -51% | -$12.1M | 1.45% | 24 |
|
|
2023
Q4 | $14.3M | Buy |
360,467
+61,992
| +21% | +$2.46M | 2.02% | 17 |
|
|
2023
Q3 | $9.52M | Buy |
298,475
+21,660
| +8% | +$691K | 1.74% | 14 |
|
|
2023
Q2 | $11.1M | Buy |
276,815
+97,525
| +54% | +$3.92M | 1.93% | 15 |
|
|
2023
Q1 | $7.66M | Buy |
179,290
+52,500
| +41% | +$2.24M | 1.67% | 23 |
|
|
2022
Q4 | $6.09M | Buy |
126,790
+26,863
| +27% | +$1.29M | 1.62% | 19 |
|
|
2022
Q3 | $3.76M | Buy |
99,927
+52,139
| +109% | +$1.96M | 1.07% | 32 |
|
|
2022
Q2 | $1.32M | Sell |
47,788
-24,902
| -34% | -$688K | 0.49% | 52 |
|
|
2022
Q1 | $3.95M | Buy |
72,690
+2,829
| +4% | +$154K | 1.16% | 32 |
|
|
2021
Q4 | $4.09M | Buy |
+69,861
| New | +$4.09M | 0.9% | 34 |
|